Biomanufacturing innovations have the potential for high impact, delivering benefits that span financial gains and societal advancements. These breakthroughs can drive increased efficiencies, reduce cost of goods (COG), and accelerate the delivery of life-changing products to patients. Join the Advanced Research Projects Agency for Health (ARPA-H), leading early-stage innovators, and members of the investment community as they explore innovative manufacturing approaches. This session will challenge traditional manufacturing paradigms and spotlight strategies to increase the likelihood of commercial adoption, offering fresh perspectives from innovators developing solutions that will transcend multiple markets. We’ll delve into topics such as novel and scalable manufacturing approaches, as well examine real and perceived risks associated with emerging biomanufacturing technologies. Learn from expert speakers as they share valuable insights and highlight unique opportunities to help bridge the gap between disruptive manufacturing technologies and market adoption.